Real-world clinical outcomes of meropenem/vaborbactam for treatment of carbapenem-resistant Enterobacterales infections

ABSTRACT: Objectives: Real-world data regarding the effectiveness of meropenem/vaborbactam (MVB) in the treatment of carbapenem-resistant Enterobacterales (CRE) infections remain limited. In this retrospective case series, we describe the outcomes of patients who received MVB for serious CRE infect...

Full description

Saved in:
Bibliographic Details
Main Authors: Helen L. Zhang, Leigh Cressman, Ebbing Lautenbach
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
CRE
Online Access:https://doaj.org/article/94ac77b172b04ac2b1060dd9d664631d
Tags: Add Tag
No Tags, Be the first to tag this record!